Target intelligence / Profile preview

CCDC121 pseudogene 1 (CCDC121P1)

Target: CCDC121P1
Molecular classification: Other (Pseudogene)

Overview

CCDC121 pseudogene 1 (CCDC121P1) is a noncoding genetic element related to the coiled-coil domain containing 121 (CCDC121) gene. Pseudogenes are genomic sequences resembling known genes but typically carry disabling mutations or regulatory changes preventing functional protein translation[2][4][5]. While previously considered "junk DNA," some pseudogenes have regulatory roles in gene expression and can influence disease processes via RNA-mediated mechanisms, including acting as competitive endogenous RNAs or miRNA sponges[2][4]. For CCDC121P1, there is no established evidence of protein-coding capacity, therapeutic targeting, or disease involvement. In summary, CCDC121 pseudogene 1 is not a classical therapeutic target. It is a noncoding pseudogene, lacking evidence for pharmacological or clinical relevance, though further research may elucidate any regulatory RNA-level functions as observed in other pseudogenes[2][4][5].

Other names: CCDC121P1CCDC121 pseudogene 1LOC643888

Mechanism of action

None. Since CCDC121P1 is a pseudogene and not a protein, no drug mechanism of action applies.

Biological functions

While most pseudogenes are nonfunctional remnants, growing evidence suggests some pseudogenes may have regulatory roles such as RNA-mediated gene expression modulation (e.g., acting as miRNA sponges, decoys, or generating regulatory RNAs).For CCDC121P1 specifically, no established functional role is documented.

Disease associations

Some pseudogenes influence disease by regulating parental genes or participating in disease-specific regulatory networks;however, no direct disease role is described for CCDC121P1 itself.

Safety considerations

None. No therapeutic interventions or safety data are relevant for pseudogenes in general, and none specifically for CCDC121P1.

Interacting drugs

None. Pseudogenes do not encode proteins for which drugs are designed to interact, and there is no known pharmacological agent targeting CCDC121P1.

Biomarkers

While certain pseudogenes have been proposed as biomarkers because of altered expression in pathological states, there is no documented use of CCDC121P1 as a biomarker.

Beyond the preview

Go deeper on CCDC121 pseudogene 1 (CCDC121P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CCDC121 pseudogene 1 (CCDC121P1).

Explore the full profile